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Summary
Non-contrast-enhanced MR angiography (MRA) of the
aorta is a robust alternative to using contrast-enhanced
(CE) angiography in the imaging of thoracic aortic dis-
eases. What is the cost impact of not using intravenous
contrast routinely in thoracic aorta MRA?
Background
Free-breathing, ECG-triggered, navigator-gated 3D seg-
mented steady state free precession (SSFP) MRA is a
promising MR technique for imaging the thoracic aorta.
We wanted to establish the economic impact of using
non-contrast enhanced angiography (non-CEMRA) in
our unit compared to the same time period last year
when only CEMRA was used.
Methods
Over a 3 month period, 22% of referrals to our cardiac
MRI unit (Siemens Aera©, Erlangen, Germany) were for
diseases of the aorta. These patients were divided into 5
subsets: 1) familial screening (Marfans, Turners, etc), 2)
dilatation, 3) follow-up aortic dissection, 4) congenital
aortic and valve disease & 5) vasculitis. 80 data sets for
patients referred for evaluation of their aorta were
examined. These were compared with 80 data sets in
patients with aortic disease imaged in a similar period
when only CEMRA was available. Clinical evaluation
included recording the patients’ serum creatinine, corre-
lation with aortic measurements from previous imaging
studies and subjective assessment of image quality. Cost
analysis included costs of contrast agent, power injector
sets and routine consumable costs associated with intra-
venous access.
Results
The unit price for consumables for thoracic aortic
CEMRA was estimated at $140CAD*/patient ($110CAD
for Gadolinium and $30CAD for other disposables).
Vasculitis patients (group 5) were excluded from both
data sets as intravenous contrast was needed for delayed
enhancement imaging. No patient was excluded from
CE-angiography due to a high serum creatinine (eGFR
in all patients ≥ 30mls/min). No patient undergoing
non-CEMRA required an additional CEMRA for a non-
diagnostic study. We examined 75 data sets in the ‘pre-
navigator’ group and 72 in the ‘post-navigator’ group. In
the pre-navigator group, 50 patients (67%) underwent
CEMRA as part of their examination: 9/12 (75%) group
1, 12/28 (43%) group 2, 2/3 (67%) group 3 and 27/32
(84%) group 4. In the post-navigator group, 14 patients
(19%) underwent CEMRA: 5/18 (28%) group 1 (268%
reduction), 6/31 (19%) group 2 (266% reduction), 1/5
(20%) group 3 (335% reduction) and 5/18 (28%) group 4
(300% reduction). Costs associated directly with
CEMRA in the pre-navigator group were $7000CAD (50
x $140CAD) and in the post-navigator group were
$1960CAD (14 x $140CAD), a saving of $5040.
*CAD = Canadian dollars.
Conclusions
We conclude that using a free-breathing, ECG-triggered,
navigator-gated 3D segmented steady state free preces-
sion (SSFP) sequence is a cost-effective way of imaging
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Table 1 Number of CEMRA performed
Group 1 familial screening Group 2 dilatation Group 3 dissection Group 4 aortic congenital disease Group 5 vasculitis
Pre-navigator 9/12 (75%) 12/28 (43%) 2/3 (67%) 27/32 (84%) 5/5 (100%)
Post-navigator 5/18 (28%) 6/31 (19%) 1/5 (20%) 5/18 (28%) 8/8 (100%)
% reduction 268% 226% 335% 300% not applicable
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